Gamma Investing LLC Cogent Biosciences, Inc. Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 302 shares of COGT stock, worth $2,823. This represents 0.0% of its overall portfolio holdings.
Number of Shares
302
Previous 510
40.78%
Holding current value
$2,823
Previous $3.06 Million
29.03%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding COGT
# of Institutions
197Shares Held
115MCall Options Held
61.9KPut Options Held
223K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$85.1 Million4.6% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY8.96MShares$83.8 Million2.75% of portfolio
-
Commodore Capital LP New York, NY8.89MShares$83.1 Million5.22% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$68.1 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$65.1 Million10.05% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $615M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...